Monograph
R03CC03 - Terbutaline |
Not porphyrinogenic |
NP |
Rationale
Rather low dose In large part not metabolised. No indication for CYP-interaction. One reference: authorised.
Chemical description
Adrenergic bronchodilator for systemic treatment (solution for injection or infusion 0,5 mg/mL) used in bronchospasm of various origin. Metabolized by sulfation, about 60% excreted in urine in unchanged form. French list: authorized
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
© NAPOS 2025